Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results alongwith the Limited Review Report as on September 30, 2025.